Johns Hopkins puts screws on industry; Ebola accident spurs new interest in vax projects;

> Yet another medical school is distancing itself from industry influence. This time, it's Johns Hopkins Medical School, whose new policy on "Interaction with Industry" will ban gifts and meals from drugmakers--and limit its doctors' speaking and consulting deals with pharma, too. FiercePharma

> A researcher who accidentally pricked herself with a needle used to infect animals with the deadly ebola virus has now become the focus of an impromptu human trial of an experimental vaccine. FierceVaccines

> La Jolla Pharmaceuticals is on the edge of the abyss after announcing in February that it's lupus drug Riquent was a bust. Not long after that the company cut an unspecified number of jobs and said it would evaluate its strategic options. FierceBiotech

And Finally... Talk about an overreaction! How about just lighting a match? Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.